Tag: CRO
BioIVT Acquires Tissue Solutions, a UK-based Virtual Biobank
BioIVT, a leading provider of research models and services for drug and diagnostic development, just announced the acquisition of Tissue Solutions Ltd., a virtual biobank based in Glasgow, UK. Tissue Solutions provides medical researchers with high quality human tissue and...
Pharmaceutical Product Development, LLC Expanding Bioanalytical Laboratory In Richmond
Pharmaceutical Product Development, LLC (PPD), is expanding
its bioanalytical laboratory in Richmond, Virginia, enhancing its ability to
provide industry-leading capabilities to meet biopharmaceutical clients’
increasing research needs. Founded in 1985, headquartered in Wilmington, North
Carolina, PPD is a leading global contract research organization providing
comprehensive,...
US Biolab Corporation Biobank
US Biolab Corporation, Inc has a global biobank with access to a diverse range of human biospecimens in various disease states to meet research needs. US Biolab biobank contains more than 500,000 human tissue (FFPE and fresh frozen), tissue...
Sekisui XenoTech Research Biobank Adds Fatty Liver Disease Assets
Sekisui XenoTech, LLC is a global Contract Research Organization (CRO). Established for almost 25 years, the company offers an ever-evolving selection of cell and tissue-based products, screening, radiolabeling, API manufacturing, in vitro ADME Tox and pharmacology, in vivo ADME...
Abzena Plc Secures Access Agreement With A Major Cell Line Depository
Abzena plc provides proprietary technologies and complementary services to enable the development and manufacture of biopharmaceutical products. Biopharmaceuticals are protein based drugs and include antibodies, antibody-drug conjugates, therapeutic proteins and peptides. ABZENA Inside products are biopharmaceutical products that incorporate...
BioDuro Acquires Molecular Response Cancer Biobank And Biorepository
BioDuro LLC is a global life sciences contract research and development organization (CRO). The company has acquired Molecular Response LLC and its extensive cancer biobank of >100,000 viable tumors, as well as its capacity as a biorepository. Molecular Response...
